Advanced search
Publication Cover
Expert Review of Vaccines Volume 5, 2006 - Issue 4
Submit an article Journal homepage
333
Views
29
CrossRef citations to date
0
Altmetric
Perspective

Are tick-borne encephalitis vaccines interchangeable?

Michael Bröker Novartis Vaccines, Clinical Research and Medical Affairs, Post Box 1630, 35006 Marburg, Germany. [email protected]
&
Ines Schöndorf Novartis Vaccines, Clinical Research and Medical Affairs, Post Box 1630, 35006 Marburg, Germany. [email protected]
Pages 461-466 | Published online: 09 Jan 2014

References

  • Dumpis U, Crook D, Oksi J. Tick-borne encephalitis. Clin. Infect. Dis.28, 882–890 (1999).
  • Löw-Baselli A, Pöllabauer EM, Fritsch A et al. FSME-Immun® – new clinical data on rapid immunization. Ellipse20, 32–33 (2004).
  • Löw-Baselli A, Pöllabauer EM, Fritsch S et al. Immunogenicity and safety of FSME-Immun® 0.5 ml using a rapid immunization schedule. Proceedings of the VIII International Potsdam Symposium on Tick-Borne Diseases (IPS-VIII), Jena, Germany, 10–12 March (2005).
  • Zent O, Bröker M. Tick-borne encephalitis vaccines: past and present. Expert Rev. Vaccines4, 747–755 (2005).
  • Barrett PN, Schober-Bendixen S, Ehrlich HJ. History of TBE vaccines. Vaccine21(Suppl. 1), 41–49 (2003).
  • Zent O, Hennig R, Banzhoff A, Bröker M. Protection against tick-borne encephalitis (TBE) with a new vaccine formulation – free of protein-derived stabilizers. J. Travel Med.12, 85–93 (2005).
  • Ecker M, Allison S, Meixner T, Heinz F. Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia. J. Gen. Virol.80, 179–185 (1999).
  • Behringwerke AG. Clinical study BI71.061/7MN-304IP, data on file (1991).
  • Pazdiora P, Januska J. Dynamika tvorby protilatek po ockovani proti klistove encefalitide. Dynamics of antibody formation after vaccination against tick born encephalitis. Epidemiol. Mikrobiol. Imunol.53, 17–21 (2004).
  • Rendi-Wagner P, Kundi M, Zent O et al. Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunisation. Vaccine23, 427–434 (2004).
  • Loew-Baselli A, Fritsch S, Pavlova BG et al. Safety and immunogenicity of FSME-Immun® ‘new’ vs. Encepur® in adults. Int. J. Med. Microbiol.293(Suppl. 37), 128–129 (2004).
  • Summeries of Product Charcteristics, Encepur®. Fachinfo-Service Germany, March (2005).
  • Summeries of Product Charcteristics, FSME-Immun®. Austria Pharma Codex, April (2006).
  • Marth E, Kleinhappl B. Albumin is a necessary stabilizer of TBE-vaccine to avoid fever in children after vaccination. Vaccine20, 532–537 (2001).

Website

  • EMEA, Committee for Human Medicinal Products (CHMP), Note for guidance on the clinical evaluation of vaccines. www.emea.eu.int/CHMP/VEG/ 164653/05

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.